[Current real-world treatments for Japanese patients with eosinophilic esophagitis].
Nihon Shokakibyo Gakkai Zasshi
; 119(10): 929-936, 2022.
Article
em Ja
| MEDLINE
| ID: mdl-36216543
ABSTRACT
A total of 306 patients with eosinophilic esophagitis (EoE) were analyzed at our department. Proton pump inhibitors or potassium-competitive acid blockers were used as the first-line treatment in 286 (93.5%) patients. Fifty-five (18.0%) patients received topical steroid swallowing therapy. During 17.7-month mean follow-up, 46.4% of the patients were followed-up with no medications, 37.3% of the patients received maintenance or on-demand therapy using acid-suppressive drugs, and 9.8% of the patients received maintenance therapy with steroid swallowing. The majority of patients with EoE were treated using a therapeutic strategy similar to that used for gastroesophageal reflux disease. However, some patients were refractory to the treatment. Current real-world treatment strategies for Japanese patients with EoE are clarified.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Refluxo Gastroesofágico
/
Esofagite Eosinofílica
Limite:
Humans
País como assunto:
Asia
Idioma:
Ja
Ano de publicação:
2022
Tipo de documento:
Article